Mild hyperthermia as a localized radiosensitizer for deep-seated tumors: investigation in an orthotopic prostate cancer model in mice
/in Hyperthermia, International PublicationsOn the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
/in Checkpoint-Inhibitors, Dendritic Cells, International PublicationsThe evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy
/in Dendritic Cells, International PublicationsEffect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells
/in Breast Cancer, International Publications, MicronutrientsDendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma
/in Dendritic Cells, International Publications, Soft Tissue SarcomaInduction of T cell-mediated immune response by dendritic cells pulsed with mRNA of sphere-forming cells isolated from patients with gastric cancer
/in Dendritic Cells, Gastric Cancer, International PublicationsAn effective dendritic cell-based vaccine containing glioma stem-like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma
/in Dendritic Cells, Glioblastoma, International PublicationsThe Role of the Status of Selected Micronutrients in Shaping the Immune Function
/in International Publications, Micronutrients
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer